0102030405
CAS No 1392275-56-7 Tenofovir Alfenamide Fumarate Pharmaceutical Intermediates
02
overview
Tenofovir Alafenamide Fumarate (TAF) is a novel tenofovir prodrug designed to more effectively deliver the active drug to target cells. It is primarily used to treat HIV-1 infection and chronic hepatitis B virus (HBV) infection.
TAF is known for its improved pharmacokinetic profile, which allows for lower doses while maintaining therapeutic efficacy.
Our TAF is manufactured in state-of-the-art facilities, ensuring it meets the highest quality and performance standards.
TAF is known for its improved pharmacokinetic profile, which allows for lower doses while maintaining therapeutic efficacy.
Our TAF is manufactured in state-of-the-art facilities, ensuring it meets the highest quality and performance standards.
02
Physical and chemical properties
- Molecular weight: 592.55g/mol
- Solubility: Highly soluble in water, easy to formulate into various dosage forms.
- Stability: Shows excellent stability under recommended storage conditions, ensuring longer shelf life.
These properties make TAF an ideal choice for formulating a wide range of pharmaceutical products, including tablets and oral solutions.
- Solubility: Highly soluble in water, easy to formulate into various dosage forms.
- Stability: Shows excellent stability under recommended storage conditions, ensuring longer shelf life.
These properties make TAF an ideal choice for formulating a wide range of pharmaceutical products, including tablets and oral solutions.
1. Enhanced Efficacy: TAF has been shown to effectively suppress viral load in HIV and hepatitis B patients, thereby improving health outcomes.
2. Reduced Dosage Requirements: Due to improved bioavailability, TAF can be administered at lower doses compared to tenofovir disoproxil fumarate, thereby reducing the risk of side effects.
3. Good safety: TAF has a complete safety profile and is the first choice for long-term treatment options.
4. Convenient medication: The once-daily medication regimen improves patient compliance and makes it easier for patients to stick to their treatment plan.
5. Combination Therapy: TAF can be effectively combined with other antiretroviral drugs to provide a powerful treatment strategy for HIV and hepatitis B.
2. Reduced Dosage Requirements: Due to improved bioavailability, TAF can be administered at lower doses compared to tenofovir disoproxil fumarate, thereby reducing the risk of side effects.
3. Good safety: TAF has a complete safety profile and is the first choice for long-term treatment options.
4. Convenient medication: The once-daily medication regimen improves patient compliance and makes it easier for patients to stick to their treatment plan.
5. Combination Therapy: TAF can be effectively combined with other antiretroviral drugs to provide a powerful treatment strategy for HIV and hepatitis B.
Tenofovir Alafenamide Fumarate is mainly used in the pharmaceutical industry to develop antiretroviral drugs. Its application range includes:
- HIV Treatment: TAF is a key component of HIV treatment and is often used in combination with other antiretroviral drugs to enhance efficacy and minimize the risk of drug resistance.
- Hepatitis B Management: TAF is also effective in managing chronic hepatitis B infection, providing patients with a reliable option.
- Research and Development: Pharmaceutical companies use TAF to explore new treatment options and formulations in clinical trials and research.
- HIV Treatment: TAF is a key component of HIV treatment and is often used in combination with other antiretroviral drugs to enhance efficacy and minimize the risk of drug resistance.
- Hepatitis B Management: TAF is also effective in managing chronic hepatitis B infection, providing patients with a reliable option.
- Research and Development: Pharmaceutical companies use TAF to explore new treatment options and formulations in clinical trials and research.
In summary, Tenofovir Alafenamide Fumarate is an important ingredient in the fight against HIV and hepatitis B. With its proven efficacy, safety and versatility, it is a valuable asset for pharmaceutical companies seeking to develop effective treatment options.
As a leading manufacturer of Tenofovir Alafenamide Fumarate, we are committed to quality and customer satisfaction. Our integrated manufacturing and trading approach enables us to offer competitive prices without compromising quality.
We understand the complexities of the pharmaceutical industry and are committed to providing our customers with high-quality products and the support they need to succeed in the market.
Partner with us to obtain high-quality TAF and enhance your product offerings in the pharmaceutical market.
As a leading manufacturer of Tenofovir Alafenamide Fumarate, we are committed to quality and customer satisfaction. Our integrated manufacturing and trading approach enables us to offer competitive prices without compromising quality.
We understand the complexities of the pharmaceutical industry and are committed to providing our customers with high-quality products and the support they need to succeed in the market.
Partner with us to obtain high-quality TAF and enhance your product offerings in the pharmaceutical market.